These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 2831891)
1. Stimulus-dependent inhibition of platelet aggregation by the protein kinase C inhibitors polymyxin B, H-7 and staurosporine. Schächtele C; Seifert R; Osswald H Biochem Biophys Res Commun; 1988 Feb; 151(1):542-7. PubMed ID: 2831891 [TBL] [Abstract][Full Text] [Related]
2. Modulation of human basophil histamine release by protein kinase C inhibitors differs with secretagogue and with inhibitor. Bergstrand H; Lundquist B; Karabelas K; Michelsen P J Pharmacol Exp Ther; 1992 Mar; 260(3):1028-37. PubMed ID: 1372047 [TBL] [Abstract][Full Text] [Related]
3. Effects of polymyxin B on superoxide anion release and priming in human polymorphonuclear leukocytes. Aida Y; Pabst MJ; Rademacher JM; Hatakeyama T; Aono M J Leukoc Biol; 1990 Mar; 47(3):283-91. PubMed ID: 2155277 [TBL] [Abstract][Full Text] [Related]
4. Inhibitors such as staurosporine, H-7 or polymyxin B cannot be used in skeletal muscle to prove the role of protein kinase C on insulin action. Gumà A; Muñoz P; Camps M; Testar X; Palacín M; Zorzano A Biosci Rep; 1992 Oct; 12(5):413-24. PubMed ID: 1290805 [TBL] [Abstract][Full Text] [Related]
5. Activation of protein kinase C by cis- and trans-octadecadienoic acids in intact human platelets and its potentiation by diacylglycerol. Seifert R; Schächtele C; Schultz G Biochem Biophys Res Commun; 1987 Dec; 149(2):762-8. PubMed ID: 3426598 [TBL] [Abstract][Full Text] [Related]
6. Protein kinase C inhibitors enhance G-protein induced phospholipase A2 activation in intact human platelets. Iorio P; Gresele P; Stasi M; Nucciarelli F; Vezza R; Nenci GG; Goracci G FEBS Lett; 1996 Mar; 381(3):244-8. PubMed ID: 8601464 [TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of H-7, H-8 and polymyxin B on liver protein kinase C-induced phosphorylation of endogenous substrates. Pugazhenthi S; Mantha SV; Khandelwal RL Biochem Int; 1990; 20(5):941-8. PubMed ID: 2161662 [TBL] [Abstract][Full Text] [Related]
8. Staurosporine inhibits STA2-induced platelet aggregation by inhibition of myosin light-chain phosphorylation in rabbit washed platelets. Takano S Ann N Y Acad Sci; 1994 Apr; 714():315-7. PubMed ID: 8017788 [No Abstract] [Full Text] [Related]
9. Na+/H+ exchange activity induced by thrombin is not inhibited by protein kinase inhibitors, staurosporine, K-252a, H-7 and sphingosine, in human platelets. Ogawa A; Ishikawa Y; Sasakawa S Thromb Res; 1993 Apr; 70(2):139-49. PubMed ID: 8391729 [TBL] [Abstract][Full Text] [Related]
10. Synthesis of phosphatidylinositol 3,4-bisphosphate is regulated by protein-tyrosine phosphorylation but the p85 alpha subunit of phosphatidylinositol 3-kinase may not be a target for tyrosine kinases in thrombin-stimulated human platelets. Yatomi Y; Ozaki Y; Satoh K; Kume S Biochim Biophys Acta; 1994 Jun; 1212(3):337-44. PubMed ID: 8199204 [TBL] [Abstract][Full Text] [Related]
11. Adenosine effects upon the spontaneous quantal transmitter release at the frog neuromuscular junction in the presence of protein kinase C-blocking and -activating agents. Brănişteanu DD; Brănişteanu DD; Covic A; Brailoiu E; Serban DN; Haulica ID Neurosci Lett; 1989 Mar; 98(1):96-100. PubMed ID: 2540461 [TBL] [Abstract][Full Text] [Related]
12. Sphingosine enhances platelet aggregation through an increase in phospholipase C activity by a protein kinase C-independent mechanism. Hashizume T; Sato T; Fujii T Biochem J; 1992 Feb; 282 ( Pt 1)(Pt 1):243-7. PubMed ID: 1540140 [TBL] [Abstract][Full Text] [Related]
13. Thrombin- and cathepsin G-induced platelet aggregation: effect of protein kinase C inhibitors. Puri RN; Colman RW Anal Biochem; 1993 Apr; 210(1):50-7. PubMed ID: 7683848 [TBL] [Abstract][Full Text] [Related]
14. Staurosporine counteracts the phorbol ester-induced enhancement of neurotransmitter release in hippocampus. Daschmann B; Allgaier C; Nakov R; Hertting G Arch Int Pharmacodyn Ther; 1988; 296():232-45. PubMed ID: 2907278 [TBL] [Abstract][Full Text] [Related]
15. Protein kinase C inhibitors suppress disc-sphere changes of human platelets, as assessed with the shape-change parameter. Ozaki Y; Jinnai Y; Yatomi Y; Kume S Eur J Pharmacol; 1993 Apr; 235(2-3):255-65. PubMed ID: 8508906 [TBL] [Abstract][Full Text] [Related]
16. Activation of phospholipase C and protein kinase C has little involvement in ADP-induced primary aggregation of human platelets: effects of diacylglycerols, the diacylglycerols, the diacylglycerol kinase inhibitor R59022, staurosporine and okadaic acid. Packham MA; Livne AA; Ruben DH; Rand ML Biochem J; 1993 Mar; 290 ( Pt 3)(Pt 3):849-56. PubMed ID: 8384448 [TBL] [Abstract][Full Text] [Related]
17. Prevention by protein kinase C inhibitors of glucose-induced insulin-receptor tyrosine kinase resistance in rat fat cells. Müller HK; Kellerer M; Ermel B; Mühlhöfer A; Obermaier-Kusser B; Vogt B; Häring HU Diabetes; 1991 Nov; 40(11):1440-8. PubMed ID: 1657668 [TBL] [Abstract][Full Text] [Related]
18. Phorbol ester-induced ventricular fibrillation in the Langendorff-perfused rabbit heart: antagonism by staurosporine and glibenclamide. Black SC; Fagbemi SO; Chi L; Friedrichs GS; Lucchesi BR J Mol Cell Cardiol; 1993 Dec; 25(12):1427-38. PubMed ID: 8158662 [TBL] [Abstract][Full Text] [Related]
19. Involvement of protein kinase C and protein tyrosine kinase pathways in tumor necrosis factor-alpha-induced clustering of ovarian theca-interstitial cells. Zachow RJ; Terranova PF Mol Cell Endocrinol; 1993 Nov; 97(1-2):37-49. PubMed ID: 8143904 [TBL] [Abstract][Full Text] [Related]
20. Effects of activators (SC-9 and OAG) and inhibitors (staurosporine and H-7) of protein kinase C on the proliferation of mouse epidermal melanoblasts in serum-free culture. Hirobe T J Cell Sci; 1994 Jun; 107 ( Pt 6)():1679-86. PubMed ID: 7962208 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]